South Korea · Delayed Price · Currency is KRW EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 196.18 billion. The enterprise value is 338.65 billion.
| Market Cap | 196.18B |
| Enterprise Value | 338.65B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
EASY BIO,Inc. has 33.08 million shares outstanding. The number of shares has decreased by -2.37% in one year.
| Current Share Class | 33.08M |
| Shares Outstanding | 33.08M |
| Shares Change (YoY) | -2.37% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 0.38% |
| Float | 16.04M |
Valuation Ratios
The trailing PE ratio is 9.93 and the forward PE ratio is 6.55.
| PE Ratio | 9.93 |
| Forward PE | 6.55 |
| PS Ratio | 0.43 |
| PB Ratio | 2.22 |
| P/TBV Ratio | 8.43 |
| P/FCF Ratio | 10.53 |
| P/OCF Ratio | 9.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.20, with an EV/FCF ratio of 18.17.
| EV / Earnings | 17.01 |
| EV / Sales | 0.74 |
| EV / EBITDA | 7.20 |
| EV / EBIT | 8.96 |
| EV / FCF | 18.17 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.89.
| Current Ratio | 1.35 |
| Quick Ratio | 0.68 |
| Debt / Equity | 1.89 |
| Debt / EBITDA | 3.57 |
| Debt / FCF | 9.00 |
| Interest Coverage | 3.89 |
Financial Efficiency
Return on equity (ROE) is 25.66% and return on invested capital (ROIC) is 8.67%.
| Return on Equity (ROE) | 25.66% |
| Return on Assets (ROA) | 7.41% |
| Return on Invested Capital (ROIC) | 8.67% |
| Return on Capital Employed (ROCE) | 21.47% |
| Revenue Per Employee | 3.45B |
| Profits Per Employee | 150.85M |
| Employee Count | 132 |
| Asset Turnover | 1.43 |
| Inventory Turnover | 7.03 |
Taxes
In the past 12 months, EASY BIO,Inc. has paid 6.12 billion in taxes.
| Income Tax | 6.12B |
| Effective Tax Rate | 22.78% |
Stock Price Statistics
The stock price has increased by +66.57% in the last 52 weeks. The beta is 1.00, so EASY BIO,Inc.'s price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | +66.57% |
| 50-Day Moving Average | 5,875.20 |
| 200-Day Moving Average | 5,319.70 |
| Relative Strength Index (RSI) | 48.58 |
| Average Volume (20 Days) | 401,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 454.77 billion and earned 19.91 billion in profits. Earnings per share was 597.42.
| Revenue | 454.77B |
| Gross Profit | 107.04B |
| Operating Income | 37.81B |
| Pretax Income | 26.86B |
| Net Income | 19.91B |
| EBITDA | 47.06B |
| EBIT | 37.81B |
| Earnings Per Share (EPS) | 597.42 |
Balance Sheet
The company has 30.49 billion in cash and 167.78 billion in debt, giving a net cash position of -137.29 billion or -4,150.07 per share.
| Cash & Cash Equivalents | 30.49B |
| Total Debt | 167.78B |
| Net Cash | -137.29B |
| Net Cash Per Share | -4,150.07 |
| Equity (Book Value) | 88.57B |
| Book Value Per Share | 2,520.65 |
| Working Capital | 43.42B |
Cash Flow
In the last 12 months, operating cash flow was 21.39 billion and capital expenditures -2.75 billion, giving a free cash flow of 18.64 billion.
| Operating Cash Flow | 21.39B |
| Capital Expenditures | -2.75B |
| Free Cash Flow | 18.64B |
| FCF Per Share | 563.40 |
Margins
Gross margin is 23.54%, with operating and profit margins of 8.31% and 4.38%.
| Gross Margin | 23.54% |
| Operating Margin | 8.31% |
| Pretax Margin | 5.91% |
| Profit Margin | 4.38% |
| EBITDA Margin | 10.35% |
| EBIT Margin | 8.31% |
| FCF Margin | 4.10% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 3.32%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 3.32% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 33.23% |
| Buyback Yield | 2.37% |
| Shareholder Yield | 5.70% |
| Earnings Yield | 10.15% |
| FCF Yield | 9.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
| Last Split Date | Dec 21, 2020 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.8 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.8 |
| Piotroski F-Score | 6 |